Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The metabolic syndrome population is at high-risk of cardiovascular diseases and diabetes. How to effectively control the risk factors of this population is the key to primary prevention of cardiovascular diseases and diabetes in China. This study aims to explore the efficacy and safety of an intervention strategy with berberine that can effectively treat a variety of risk factors (hyperglycemia, dyslipidemia, hypertension).
Epistemonikos ID: 851af1ff02a35fd22be06f205c086a5d1a559a0f
First added on: May 09, 2024